Activision Blizzard Inc. (ATVI) And Johnson & Johnson (JNJ) Are Stocks To Watch

You should consider shares of Activision Blizzard Inc. (NASDAQ:ATVI) and Johnson & Johnson (NYSE:JNJ) if you are looking for a great stocks to invest in. Starting with the ATVI shares, which traded at $59.64 at the close of the recent session, dropping -0.68%. On Wednesday, the company’s shares shed -$0.41 from its value which represented in intraday trading. The stock is now 0.37% higher in year-to-date (YTD) trading. ATVI’s intraday high was $60.45 while its lowest price touched $59.28. The stock’s 52-week high price is $60.88, which means the current price is at -2.04%. In terms of trading activity, the daily trading volume fell to 5643686 against 200-day average trading volume of 6,835,744 shares.

What are analyst forecasts for Activision Blizzard Inc. (NASDAQ:ATVI)?

At a consensus rating of 4.27, ATVI is trending as a streaking Moderate Buy, as it has been the case a month ago when 22 analysts called it a Moderate Buy. Two months ago, 23 analysts recommended, on average, that ATVI stock is a Moderate Buy. The Technology company’s shares’ overall bearish trend saw it close higher on Wednesday compared to its opening price of $60.05 on the day.

Forecasts for Activision Blizzard Inc. (NASDAQ:ATVI) give the stock a fair value for the growth from its last price.

The consensus among 34 analysts is that it is a good time for one to Overweight in the Activision Blizzard Inc. 22 analysts rate ATVI as a Buy, with 0 of 34 analysts rate it as a Sell. 3 have valued the stock as Overweight and 8 have recommended that investors Hold.

Activision Blizzard Inc. (NASDAQ:ATVI) Upgrades and Downgrades

In terms of rating changes, Nomura on January 14, 2020, Reiterated Activision Blizzard Inc. (ATVI) at Buy. They believe the stock could reach $70 in the near term. Analysts at The Benchmark Company have assigned a Buy rating for the stock in their research note on January 06, 2020 with an estimated price target of $72. Moreover, Bernstein analysts issued a rating of Underperform for the stock on October 02, 2019, giving it a price target of $43 for the next 12 months. On September 09, 2019, the stock earned a Buy rating due to an analyst call from Stifel, while analysts from Stephens on September 05, 2019 suggested that the stock is Overweight.

Johnson & Johnson (NYSE:JNJ) adds $0.49 on Wednesday

The JNJ stock has risen 0.78% year-to-date and is currently trading at $147.01, which is -0.56% below its 52-week high. The company shares gained 0.33% on the day and have risen nearly 17.61% off a low hit. At current levels, Johnson & Johnson has a valuation of about $81.71B. As of 01/15/20, this stock has risen 1.41% during the week and closed at $146.52 in the previous session. However, recent Johnson & Johnson stock performance shows that JNJ shares are 3.98% up over the last month, and 10.67% up for the last three months.

Earnings per share (EPS) estimates for the current quarter are $1.95, with the trailing 12-month share earnings at $5.25. The ratio is expected to be up by 5.90% for the current year 2019 and 5.00% for next year. Over the next 5-year period, earnings per share will be 5.87%. But will the JNJ stock surprise in the current quarter results, where the $2.12 actual EPS reported on 9/29/2019 surprised by 5.50% or was higher by $0.11 from the estimated $2.01.

Sales Growth to climb 4.00% for the year

How well will Johnson & Johnson perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $20.1B and $20.98B in current quarter sales. The consensus estimated for the current quarter is $20.78B from sales. Forecasts for this fiscal year are between $81.4B and $82.44B and the consensus estimate for sales is at $82.11B. JNJ has its next quarter sales estimates at between $20.24B and $20.88B, with the quarter-over-quarter growth estimates at 2.60% and the annual growth forecast for the year at 4.00%.

Who owns shares in Johnson & Johnson (JNJ)?

Let’s briefly focus on the share ownership of the Johnson & Johnson (NYSE:JNJ) stock, where we find that 69.67% of shares are held by institutions. Vanguard Group, Inc. (The) tops the list of institutional owners as it is holding 226.03 million shares or 8.59% of shares outstanding. Blackrock Inc. and State Street Corporation held 188.63 million and 151.53 million representing 7.17% and 5.76% respectively at the close of the last trading session. As of Sep 29, 2019, State Farm Mutual Automobile Insurance Co accounted for 37.88 million shares at over 4.9 billion. This represented 1.44% of shares outstanding. Geode Capital Management, LLC held 37.03 million shares at over 4.79 billion representing 1.41% of shares outstanding.

JNJ Insider Activity

Insider activity can also give a signal in terms of price direction. Looking at Johnson & Johnson (JNJ), a total of 2017 shares have been sold by insiders over the last 6 months while 7017 shares were added in the same time span. On 2/11/2019, Chairman & Chief Executive Officer by the name Gorsky Alex sold 37374.0 shares worth $4.9 million at the price of $131.94 per share. Filings also show that Stoffels Paulus sold a total of 15884.0 shares on 2/11/2019 valued at $2.1 million. Since the last insider activity, the company’s share price has climbed 11.37%.